RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study
RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study
Sponsor: RxSight, Inc.
A NA clinical study on Aphakia and Cataract, this trial is completed. The trial is conducted by RxSight, Inc. and has accumulated 13 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
May 2025 — Sep 2025 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2024 — May 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Feb 2024 — Jul 2024 [monthly]
Recruiting NA
-
Sep 2023 — Feb 2024 [monthly]
Recruiting NA
-
Apr 2023 — Sep 2023 [monthly]
Recruiting NA
-
Jan 2023 — Apr 2023 [monthly]
Recruiting NA
-
Sep 2022 — Jan 2023 [monthly]
Recruiting NA
-
Jun 2022 — Sep 2022 [monthly]
Recruiting NA
-
Mar 2022 — Jun 2022 [monthly]
Recruiting NA
-
Feb 2022 — Mar 2022 [monthly]
Recruiting NA
First recorded
Dec 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- RxSight, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .